nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—Erlotinib—pancreatic cancer	0.332	0.526	CbGbCtD
Testosterone Propionate—UGT1A1—Irinotecan—pancreatic cancer	0.3	0.475	CbGbCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.00222	0.0454	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—NR5A2—pancreatic cancer	0.00209	0.0428	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—RBBP8—pancreatic cancer	0.00167	0.0342	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00165	0.0338	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00151	0.0309	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—FGF13—pancreatic cancer	0.00138	0.0282	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.00125	0.0256	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.00116	0.0237	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00114	0.0234	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.00102	0.0209	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.001	0.0205	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.000974	0.0199	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.000918	0.0188	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.000788	0.0161	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000686	0.014	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.000601	0.0123	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.000586	0.012	CbGpPWpGaD
Testosterone Propionate—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000577	0.0018	CcSEcCtD
Testosterone Propionate—Asthenia—Tamoxifen—pancreatic cancer	0.000573	0.00179	CcSEcCtD
Testosterone Propionate—Arthralgia—Gemcitabine—pancreatic cancer	0.000572	0.00179	CcSEcCtD
Testosterone Propionate—Myalgia—Gemcitabine—pancreatic cancer	0.000572	0.00179	CcSEcCtD
Testosterone Propionate—Increased appetite—Epirubicin—pancreatic cancer	0.000569	0.00178	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000568	0.00178	CcSEcCtD
Testosterone Propionate—Confusional state—Irinotecan—pancreatic cancer	0.000568	0.00178	CcSEcCtD
Testosterone Propionate—Asthenia—Erlotinib—pancreatic cancer	0.000567	0.00177	CcSEcCtD
Testosterone Propionate—Discomfort—Gemcitabine—pancreatic cancer	0.000565	0.00177	CcSEcCtD
Testosterone Propionate—Pruritus—Tamoxifen—pancreatic cancer	0.000565	0.00177	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000564	0.0115	CbGpPWpGaD
Testosterone Propionate—Oedema—Irinotecan—pancreatic cancer	0.000563	0.00176	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000563	0.00176	CcSEcCtD
Testosterone Propionate—Myalgia—Fluorouracil—pancreatic cancer	0.000563	0.00176	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000559	0.00175	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000559	0.00175	CcSEcCtD
Testosterone Propionate—Pruritus—Erlotinib—pancreatic cancer	0.000559	0.00175	CcSEcCtD
Testosterone Propionate—Discomfort—Fluorouracil—pancreatic cancer	0.000556	0.00174	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Irinotecan—pancreatic cancer	0.000552	0.00173	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000552	0.00173	CcSEcCtD
Testosterone Propionate—Haemoglobin—Docetaxel—pancreatic cancer	0.000551	0.00172	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000549	0.00172	CcSEcCtD
Testosterone Propionate—Oedema—Gemcitabine—pancreatic cancer	0.000549	0.00172	CcSEcCtD
Testosterone Propionate—Haemorrhage—Docetaxel—pancreatic cancer	0.000548	0.00171	CcSEcCtD
Testosterone Propionate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000546	0.00171	CcSEcCtD
Testosterone Propionate—Confusional state—Fluorouracil—pancreatic cancer	0.000544	0.0017	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000543	0.0111	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000541	0.00169	CcSEcCtD
Testosterone Propionate—Abdominal pain—Sunitinib—pancreatic cancer	0.000541	0.00169	CcSEcCtD
Testosterone Propionate—Diarrhoea—Erlotinib—pancreatic cancer	0.00054	0.00169	CcSEcCtD
Testosterone Propionate—Oedema—Fluorouracil—pancreatic cancer	0.000539	0.00169	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000539	0.00169	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000539	0.00168	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000538	0.00168	CcSEcCtD
Testosterone Propionate—Urethral disorder—Docetaxel—pancreatic cancer	0.000537	0.00168	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000534	0.00167	CcSEcCtD
Testosterone Propionate—Skin disorder—Gemcitabine—pancreatic cancer	0.000533	0.00167	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000529	0.00165	CcSEcCtD
Testosterone Propionate—Dizziness—Tamoxifen—pancreatic cancer	0.000528	0.00165	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—pancreatic cancer	0.000526	0.00165	CcSEcCtD
Testosterone Propionate—Dizziness—Erlotinib—pancreatic cancer	0.000522	0.00163	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000517	0.00162	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000511	0.0016	CcSEcCtD
Testosterone Propionate—Insomnia—Irinotecan—pancreatic cancer	0.000509	0.00159	CcSEcCtD
Testosterone Propionate—Vomiting—Tamoxifen—pancreatic cancer	0.000508	0.00159	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.000507	0.0104	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Irinotecan—pancreatic cancer	0.000506	0.00158	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Sunitinib—pancreatic cancer	0.000504	0.00157	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.000503	0.0103	CbGpPWpGaD
Testosterone Propionate—Rash—Tamoxifen—pancreatic cancer	0.000503	0.00157	CcSEcCtD
Testosterone Propionate—Dermatitis—Tamoxifen—pancreatic cancer	0.000503	0.00157	CcSEcCtD
Testosterone Propionate—Vomiting—Erlotinib—pancreatic cancer	0.000502	0.00157	CcSEcCtD
Testosterone Propionate—Dyspnoea—Irinotecan—pancreatic cancer	0.000502	0.00157	CcSEcCtD
Testosterone Propionate—Headache—Tamoxifen—pancreatic cancer	0.0005	0.00156	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.0005	0.00156	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000498	0.0102	CbGpPWpGaD
Testosterone Propionate—Rash—Erlotinib—pancreatic cancer	0.000498	0.00156	CcSEcCtD
Testosterone Propionate—Dermatitis—Erlotinib—pancreatic cancer	0.000498	0.00156	CcSEcCtD
Testosterone Propionate—Angiopathy—Docetaxel—pancreatic cancer	0.000497	0.00155	CcSEcCtD
Testosterone Propionate—Insomnia—Gemcitabine—pancreatic cancer	0.000496	0.00155	CcSEcCtD
Testosterone Propionate—Immune system disorder—Docetaxel—pancreatic cancer	0.000495	0.00155	CcSEcCtD
Testosterone Propionate—Headache—Erlotinib—pancreatic cancer	0.000495	0.00155	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000494	0.00155	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000494	0.00154	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000493	0.00154	CcSEcCtD
Testosterone Propionate—Paraesthesia—Gemcitabine—pancreatic cancer	0.000493	0.00154	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000491	0.00154	CcSEcCtD
Testosterone Propionate—Asthenia—Sunitinib—pancreatic cancer	0.000491	0.00153	CcSEcCtD
Testosterone Propionate—Dyspnoea—Gemcitabine—pancreatic cancer	0.000489	0.00153	CcSEcCtD
Testosterone Propionate—Insomnia—Fluorouracil—pancreatic cancer	0.000488	0.00153	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000486	0.00152	CcSEcCtD
Testosterone Propionate—Fatigue—Irinotecan—pancreatic cancer	0.000486	0.00152	CcSEcCtD
Testosterone Propionate—Paraesthesia—Fluorouracil—pancreatic cancer	0.000484	0.00151	CcSEcCtD
Testosterone Propionate—Alopecia—Docetaxel—pancreatic cancer	0.000484	0.00151	CcSEcCtD
Testosterone Propionate—Pruritus—Sunitinib—pancreatic cancer	0.000484	0.00151	CcSEcCtD
Testosterone Propionate—Breast disorder—Epirubicin—pancreatic cancer	0.000483	0.00151	CcSEcCtD
Testosterone Propionate—Pain—Irinotecan—pancreatic cancer	0.000482	0.00151	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.000481	0.00985	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Fluorouracil—pancreatic cancer	0.000481	0.0015	CcSEcCtD
Testosterone Propionate—Mental disorder—Docetaxel—pancreatic cancer	0.00048	0.0015	CcSEcCtD
Testosterone Propionate—Malnutrition—Docetaxel—pancreatic cancer	0.000477	0.00149	CcSEcCtD
Testosterone Propionate—Nausea—Tamoxifen—pancreatic cancer	0.000474	0.00148	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000474	0.00148	CcSEcCtD
Testosterone Propionate—Fatigue—Gemcitabine—pancreatic cancer	0.000473	0.00148	CcSEcCtD
Testosterone Propionate—Pain—Gemcitabine—pancreatic cancer	0.000469	0.00147	CcSEcCtD
Testosterone Propionate—Nausea—Erlotinib—pancreatic cancer	0.000469	0.00147	CcSEcCtD
Testosterone Propionate—Diarrhoea—Sunitinib—pancreatic cancer	0.000468	0.00146	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000466	0.00146	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000464	0.00145	CcSEcCtD
Testosterone Propionate—Pain—Fluorouracil—pancreatic cancer	0.000461	0.00144	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000461	0.00144	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000456	0.00143	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.000454	0.00928	CbGpPWpGaD
Testosterone Propionate—Dizziness—Sunitinib—pancreatic cancer	0.000452	0.00141	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000452	0.00141	CcSEcCtD
Testosterone Propionate—Breast disorder—Doxorubicin—pancreatic cancer	0.000447	0.0014	CcSEcCtD
Testosterone Propionate—Abdominal pain—Irinotecan—pancreatic cancer	0.000445	0.00139	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000445	0.00139	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000444	0.00909	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.000435	0.0089	CbGpPWpGaD
Testosterone Propionate—Vomiting—Sunitinib—pancreatic cancer	0.000435	0.00136	CcSEcCtD
Testosterone Propionate—Dysuria—Epirubicin—pancreatic cancer	0.000432	0.00135	CcSEcCtD
Testosterone Propionate—Rash—Sunitinib—pancreatic cancer	0.000431	0.00135	CcSEcCtD
Testosterone Propionate—Dermatitis—Sunitinib—pancreatic cancer	0.000431	0.00135	CcSEcCtD
Testosterone Propionate—Urticaria—Fluorouracil—pancreatic cancer	0.000429	0.00134	CcSEcCtD
Testosterone Propionate—Headache—Sunitinib—pancreatic cancer	0.000428	0.00134	CcSEcCtD
Testosterone Propionate—Weight increased—Epirubicin—pancreatic cancer	0.00042	0.00131	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000415	0.0013	CcSEcCtD
Testosterone Propionate—Hypertension—Docetaxel—pancreatic cancer	0.000412	0.00129	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	0.00041	0.00838	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Docetaxel—pancreatic cancer	0.000406	0.00127	CcSEcCtD
Testosterone Propionate—Myalgia—Docetaxel—pancreatic cancer	0.000406	0.00127	CcSEcCtD
Testosterone Propionate—Nausea—Sunitinib—pancreatic cancer	0.000406	0.00127	CcSEcCtD
Testosterone Propionate—Asthenia—Irinotecan—pancreatic cancer	0.000404	0.00126	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000403	0.00126	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000401	0.0082	CbGpPWpGaD
Testosterone Propionate—Dysuria—Doxorubicin—pancreatic cancer	0.0004	0.00125	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.000398	0.00815	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000397	0.00124	CcSEcCtD
Testosterone Propionate—Asthenia—Gemcitabine—pancreatic cancer	0.000394	0.00123	CcSEcCtD
Testosterone Propionate—Haematuria—Epirubicin—pancreatic cancer	0.000393	0.00123	CcSEcCtD
Testosterone Propionate—Confusional state—Docetaxel—pancreatic cancer	0.000393	0.00123	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000389	0.00122	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000389	0.00122	CcSEcCtD
Testosterone Propionate—Oedema—Docetaxel—pancreatic cancer	0.000389	0.00122	CcSEcCtD
Testosterone Propionate—Weight increased—Doxorubicin—pancreatic cancer	0.000389	0.00122	CcSEcCtD
Testosterone Propionate—Pruritus—Gemcitabine—pancreatic cancer	0.000388	0.00121	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—NFE2L2—pancreatic cancer	0.000387	0.00791	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Irinotecan—pancreatic cancer	0.000385	0.0012	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000382	0.00119	CcSEcCtD
Testosterone Propionate—Pruritus—Fluorouracil—pancreatic cancer	0.000382	0.00119	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	0.00038	0.00777	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Docetaxel—pancreatic cancer	0.000378	0.00118	CcSEcCtD
Testosterone Propionate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000375	0.00117	CcSEcCtD
Testosterone Propionate—Dizziness—Irinotecan—pancreatic cancer	0.000372	0.00116	CcSEcCtD
Testosterone Propionate—Haemoglobin—Epirubicin—pancreatic cancer	0.000372	0.00116	CcSEcCtD
Testosterone Propionate—Haemorrhage—Epirubicin—pancreatic cancer	0.00037	0.00116	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	0.000369	0.00755	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000369	0.00115	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFA—pancreatic cancer	0.000369	0.00755	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000365	0.00114	CcSEcCtD
Testosterone Propionate—Haematuria—Doxorubicin—pancreatic cancer	0.000363	0.00114	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000363	0.00114	CcSEcCtD
Testosterone Propionate—Urethral disorder—Epirubicin—pancreatic cancer	0.000362	0.00113	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC2A2—pancreatic cancer	0.000361	0.00739	CbGpPWpGaD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00036	0.00113	CcSEcCtD
Testosterone Propionate—Vomiting—Irinotecan—pancreatic cancer	0.000358	0.00112	CcSEcCtD
Testosterone Propionate—Dizziness—Fluorouracil—pancreatic cancer	0.000357	0.00112	CcSEcCtD
Testosterone Propionate—Rash—Irinotecan—pancreatic cancer	0.000355	0.00111	CcSEcCtD
Testosterone Propionate—Dermatitis—Irinotecan—pancreatic cancer	0.000355	0.00111	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000355	0.00111	CcSEcCtD
Testosterone Propionate—Headache—Irinotecan—pancreatic cancer	0.000353	0.0011	CcSEcCtD
Testosterone Propionate—Insomnia—Docetaxel—pancreatic cancer	0.000352	0.0011	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000351	0.00718	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Docetaxel—pancreatic cancer	0.00035	0.00109	CcSEcCtD
Testosterone Propionate—Vomiting—Gemcitabine—pancreatic cancer	0.000349	0.00109	CcSEcCtD
Testosterone Propionate—Dyspnoea—Docetaxel—pancreatic cancer	0.000347	0.00109	CcSEcCtD
Testosterone Propionate—Rash—Gemcitabine—pancreatic cancer	0.000346	0.00108	CcSEcCtD
Testosterone Propionate—Dermatitis—Gemcitabine—pancreatic cancer	0.000346	0.00108	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	0.000344	0.00704	CbGpPWpGaD
Testosterone Propionate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000344	0.00107	CcSEcCtD
Testosterone Propionate—Headache—Gemcitabine—pancreatic cancer	0.000344	0.00107	CcSEcCtD
Testosterone Propionate—Vomiting—Fluorouracil—pancreatic cancer	0.000343	0.00107	CcSEcCtD
Testosterone Propionate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000342	0.00107	CcSEcCtD
Testosterone Propionate—Rash—Fluorouracil—pancreatic cancer	0.00034	0.00106	CcSEcCtD
Testosterone Propionate—Dermatitis—Fluorouracil—pancreatic cancer	0.00034	0.00106	CcSEcCtD
Testosterone Propionate—Headache—Fluorouracil—pancreatic cancer	0.000338	0.00106	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000338	0.00106	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000336	0.00105	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000336	0.00105	CcSEcCtD
Testosterone Propionate—Fatigue—Docetaxel—pancreatic cancer	0.000336	0.00105	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—pancreatic cancer	0.000335	0.00105	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000335	0.00105	CcSEcCtD
Testosterone Propionate—Nausea—Irinotecan—pancreatic cancer	0.000335	0.00105	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—pancreatic cancer	0.000334	0.00104	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000333	0.00104	CcSEcCtD
Testosterone Propionate—Pain—Docetaxel—pancreatic cancer	0.000333	0.00104	CcSEcCtD
Testosterone Propionate—Alopecia—Epirubicin—pancreatic cancer	0.000327	0.00102	CcSEcCtD
Testosterone Propionate—Nausea—Gemcitabine—pancreatic cancer	0.000326	0.00102	CcSEcCtD
Testosterone Propionate—Mental disorder—Epirubicin—pancreatic cancer	0.000324	0.00101	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.000322	0.0066	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Epirubicin—pancreatic cancer	0.000322	0.00101	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000321	0.00657	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000321	0.001	CcSEcCtD
Testosterone Propionate—Nausea—Fluorouracil—pancreatic cancer	0.00032	0.001	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000318	0.000995	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000315	0.00644	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000311	0.00636	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Doxorubicin—pancreatic cancer	0.00031	0.00097	CcSEcCtD
Testosterone Propionate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000309	0.000966	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000308	0.000964	CcSEcCtD
Testosterone Propionate—Abdominal pain—Docetaxel—pancreatic cancer	0.000308	0.000962	CcSEcCtD
Testosterone Propionate—Alopecia—Doxorubicin—pancreatic cancer	0.000302	0.000945	CcSEcCtD
Testosterone Propionate—Mental disorder—Doxorubicin—pancreatic cancer	0.0003	0.000937	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000299	0.000933	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—pancreatic cancer	0.000298	0.000931	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	0.000292	0.00598	CbGpPWpGaD
Testosterone Propionate—Malaise—Epirubicin—pancreatic cancer	0.00029	0.000907	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	0.000289	0.00591	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000287	0.000897	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000285	0.00584	CbGpPWpGaD
Testosterone Propionate—Asthenia—Docetaxel—pancreatic cancer	0.000279	0.000873	CcSEcCtD
Testosterone Propionate—Hypertension—Epirubicin—pancreatic cancer	0.000278	0.000869	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—HSPA1A—pancreatic cancer	0.000278	0.00568	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000276	0.000864	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.000276	0.00565	CbGpPWpGaD
Testosterone Propionate—Pruritus—Docetaxel—pancreatic cancer	0.000275	0.000861	CcSEcCtD
Testosterone Propionate—Myalgia—Epirubicin—pancreatic cancer	0.000274	0.000856	CcSEcCtD
Testosterone Propionate—Arthralgia—Epirubicin—pancreatic cancer	0.000274	0.000856	CcSEcCtD
Testosterone Propionate—Anxiety—Epirubicin—pancreatic cancer	0.000273	0.000853	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000272	0.000851	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000272	0.00556	CbGpPWpGaD
Testosterone Propionate—Discomfort—Epirubicin—pancreatic cancer	0.000271	0.000846	CcSEcCtD
Testosterone Propionate—Malaise—Doxorubicin—pancreatic cancer	0.000268	0.000839	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	0.000267	0.00547	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000267	0.00547	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	0.000267	0.00546	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Docetaxel—pancreatic cancer	0.000266	0.000833	CcSEcCtD
Testosterone Propionate—Confusional state—Epirubicin—pancreatic cancer	0.000265	0.000828	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	0.000263	0.00537	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000263	0.000821	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—pancreatic cancer	0.000263	0.000821	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000258	0.000805	CcSEcCtD
Testosterone Propionate—Dizziness—Docetaxel—pancreatic cancer	0.000257	0.000805	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—pancreatic cancer	0.000257	0.000804	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	0.000257	0.00525	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Epirubicin—pancreatic cancer	0.000255	0.000797	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—pancreatic cancer	0.000253	0.000792	CcSEcCtD
Testosterone Propionate—Arthralgia—Doxorubicin—pancreatic cancer	0.000253	0.000792	CcSEcCtD
Testosterone Propionate—Anxiety—Doxorubicin—pancreatic cancer	0.000253	0.00079	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000252	0.000787	CcSEcCtD
Testosterone Propionate—Discomfort—Doxorubicin—pancreatic cancer	0.00025	0.000783	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.00025	0.00511	CbGpPWpGaD
Testosterone Propionate—Vomiting—Docetaxel—pancreatic cancer	0.000248	0.000774	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000247	0.00506	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	0.000247	0.00505	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	0.000246	0.00504	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	0.000246	0.00503	CbGpPWpGaD
Testosterone Propionate—Rash—Docetaxel—pancreatic cancer	0.000245	0.000767	CcSEcCtD
Testosterone Propionate—Dermatitis—Docetaxel—pancreatic cancer	0.000245	0.000767	CcSEcCtD
Testosterone Propionate—Confusional state—Doxorubicin—pancreatic cancer	0.000245	0.000766	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	0.000245	0.005	CbGpPWpGaD
Testosterone Propionate—Headache—Docetaxel—pancreatic cancer	0.000244	0.000763	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—pancreatic cancer	0.000243	0.00076	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000243	0.00076	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000242	0.00495	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000239	0.000748	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000238	0.000745	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—pancreatic cancer	0.000238	0.000743	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	0.000236	0.00483	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Doxorubicin—pancreatic cancer	0.000236	0.000738	CcSEcCtD
Testosterone Propionate—Paraesthesia—Epirubicin—pancreatic cancer	0.000236	0.000737	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	0.000235	0.00482	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Epirubicin—pancreatic cancer	0.000234	0.000732	CcSEcCtD
Testosterone Propionate—Nausea—Docetaxel—pancreatic cancer	0.000231	0.000723	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.00023	0.00471	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000229	0.00468	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000227	0.000709	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—pancreatic cancer	0.000226	0.000708	CcSEcCtD
Testosterone Propionate—Pain—Epirubicin—pancreatic cancer	0.000225	0.000702	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000221	0.000692	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	0.00022	0.0045	CbGpPWpGaD
Testosterone Propionate—Insomnia—Doxorubicin—pancreatic cancer	0.00022	0.000687	CcSEcCtD
Testosterone Propionate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000218	0.000682	CcSEcCtD
Testosterone Propionate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000217	0.000677	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000216	0.000677	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	0.000216	0.00441	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000215	0.000671	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	0.000213	0.00437	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00021	0.000656	CcSEcCtD
Testosterone Propionate—Fatigue—Doxorubicin—pancreatic cancer	0.000209	0.000655	CcSEcCtD
Testosterone Propionate—Urticaria—Epirubicin—pancreatic cancer	0.000209	0.000652	CcSEcCtD
Testosterone Propionate—Pain—Doxorubicin—pancreatic cancer	0.000208	0.00065	CcSEcCtD
Testosterone Propionate—Abdominal pain—Epirubicin—pancreatic cancer	0.000208	0.000649	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000207	0.00423	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	0.000205	0.0042	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.0002	0.0041	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.0002	0.000626	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	0.000199	0.00407	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000199	0.000621	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000197	0.00404	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	0.000197	0.00403	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000197	0.00403	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000193	0.000605	CcSEcCtD
Testosterone Propionate—Urticaria—Doxorubicin—pancreatic cancer	0.000193	0.000603	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	0.000193	0.00395	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000193	0.00395	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000192	0.000601	CcSEcCtD
Testosterone Propionate—Asthenia—Epirubicin—pancreatic cancer	0.000188	0.000589	CcSEcCtD
Testosterone Propionate—Pruritus—Epirubicin—pancreatic cancer	0.000186	0.000581	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.000183	0.00374	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.000181	0.0037	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—pancreatic cancer	0.00018	0.000562	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000179	0.00056	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.000176	0.00361	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—pancreatic cancer	0.000174	0.000545	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—pancreatic cancer	0.000174	0.000543	CcSEcCtD
Testosterone Propionate—Pruritus—Doxorubicin—pancreatic cancer	0.000172	0.000537	CcSEcCtD
Testosterone Propionate—Vomiting—Epirubicin—pancreatic cancer	0.000167	0.000522	CcSEcCtD
Testosterone Propionate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000166	0.00052	CcSEcCtD
Testosterone Propionate—Rash—Epirubicin—pancreatic cancer	0.000166	0.000518	CcSEcCtD
Testosterone Propionate—Dermatitis—Epirubicin—pancreatic cancer	0.000165	0.000517	CcSEcCtD
Testosterone Propionate—Headache—Epirubicin—pancreatic cancer	0.000165	0.000514	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—CHD3—pancreatic cancer	0.000164	0.00336	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000164	0.00336	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.000163	0.00334	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000161	0.0033	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—pancreatic cancer	0.000161	0.000502	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.00016	0.00328	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	0.000159	0.00326	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PRSS1—pancreatic cancer	0.000159	0.00324	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000158	0.00323	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.000158	0.00322	CbGpPWpGaD
Testosterone Propionate—Nausea—Epirubicin—pancreatic cancer	0.000156	0.000488	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000155	0.00318	CbGpPWpGaD
Testosterone Propionate—Vomiting—Doxorubicin—pancreatic cancer	0.000154	0.000483	CcSEcCtD
Testosterone Propionate—Rash—Doxorubicin—pancreatic cancer	0.000153	0.000479	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—pancreatic cancer	0.000153	0.000479	CcSEcCtD
Testosterone Propionate—Headache—Doxorubicin—pancreatic cancer	0.000152	0.000476	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—PRSS1—pancreatic cancer	0.000152	0.00311	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000149	0.00305	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—pancreatic cancer	0.000144	0.000451	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.000143	0.00293	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000143	0.00292	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NR5A2—pancreatic cancer	0.000137	0.00281	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ARG2—pancreatic cancer	0.000137	0.00281	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	0.000137	0.00281	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000132	0.0027	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ARG2—pancreatic cancer	0.000132	0.00269	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000125	0.00256	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000123	0.00251	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TYMP—pancreatic cancer	0.00012	0.00246	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.00012	0.00245	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.00012	0.00245	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000118	0.00242	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000115	0.00236	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000115	0.00236	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMP—pancreatic cancer	0.000115	0.00235	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.00011	0.00224	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000109	0.00224	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000104	0.00213	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000102	0.00208	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000102	0.00208	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000102	0.00208	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	9.95e-05	0.00204	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	9.91e-05	0.00203	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	9.81e-05	0.00201	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GLP1R—pancreatic cancer	9.68e-05	0.00198	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	9.59e-05	0.00196	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	9.57e-05	0.00196	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—DPYD—pancreatic cancer	9.53e-05	0.00195	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PRSS1—pancreatic cancer	9.5e-05	0.00194	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.49e-05	0.00194	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	9.38e-05	0.00192	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GLP1R—pancreatic cancer	9.27e-05	0.0019	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—DPYD—pancreatic cancer	9.12e-05	0.00187	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC2A2—pancreatic cancer	9.04e-05	0.00185	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—pancreatic cancer	8.92e-05	0.00183	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	8.87e-05	0.00182	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	8.86e-05	0.00181	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB1—pancreatic cancer	8.73e-05	0.00179	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	8.71e-05	0.00178	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC2A2—pancreatic cancer	8.66e-05	0.00177	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	8.64e-05	0.00177	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.57e-05	0.00175	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.27e-05	0.00169	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ARG2—pancreatic cancer	8.23e-05	0.00168	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	7.95e-05	0.00163	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	7.93e-05	0.00162	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MEN1—pancreatic cancer	7.89e-05	0.00162	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	7.88e-05	0.00161	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	7.77e-05	0.00159	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.53e-05	0.00154	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH4—pancreatic cancer	7.48e-05	0.00153	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.4e-05	0.00152	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.34e-05	0.0015	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	7.34e-05	0.0015	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMP—pancreatic cancer	7.2e-05	0.00147	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HSPA1B—pancreatic cancer	7.14e-05	0.00146	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CD44—pancreatic cancer	7e-05	0.00143	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	6.93e-05	0.00142	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—pancreatic cancer	6.84e-05	0.0014	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	6.75e-05	0.00138	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GCG—pancreatic cancer	6.71e-05	0.00137	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CD44—pancreatic cancer	6.7e-05	0.00137	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	6.65e-05	0.00136	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.56e-05	0.00134	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.53e-05	0.00134	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.5e-05	0.00133	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—EZH2—pancreatic cancer	6.5e-05	0.00133	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GCG—pancreatic cancer	6.43e-05	0.00132	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH3—pancreatic cancer	6.36e-05	0.0013	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—STK11—pancreatic cancer	6.31e-05	0.00129	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—STK11—pancreatic cancer	6.04e-05	0.00124	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HSPA1A—pancreatic cancer	6.03e-05	0.00123	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GLP1R—pancreatic cancer	5.8e-05	0.00119	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—DPYD—pancreatic cancer	5.71e-05	0.00117	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.67e-05	0.00116	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.51e-05	0.00113	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TYMS—pancreatic cancer	5.43e-05	0.00111	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC2A2—pancreatic cancer	5.42e-05	0.00111	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMS—pancreatic cancer	5.2e-05	0.00106	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SMAD4—pancreatic cancer	4.79e-05	0.000981	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—APOE—pancreatic cancer	4.41e-05	0.000903	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—APOE—pancreatic cancer	4.23e-05	0.000865	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CD44—pancreatic cancer	4.19e-05	0.000858	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GCG—pancreatic cancer	4.02e-05	0.000823	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4e-05	0.000819	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CG—pancreatic cancer	3.98e-05	0.000815	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—pancreatic cancer	3.95e-05	0.000808	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARG—pancreatic cancer	3.85e-05	0.000787	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CG—pancreatic cancer	3.82e-05	0.000781	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—STK11—pancreatic cancer	3.78e-05	0.000774	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARG—pancreatic cancer	3.68e-05	0.000754	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH1—pancreatic cancer	3.53e-05	0.000723	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CD—pancreatic cancer	3.5e-05	0.000717	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CD—pancreatic cancer	3.35e-05	0.000686	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARG—pancreatic cancer	3.33e-05	0.000682	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMS—pancreatic cancer	3.25e-05	0.000665	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CB—pancreatic cancer	3.05e-05	0.000625	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—pancreatic cancer	3.02e-05	0.000619	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CB—pancreatic cancer	2.92e-05	0.000598	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—pancreatic cancer	2.9e-05	0.000593	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—APOE—pancreatic cancer	2.64e-05	0.000541	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—pancreatic cancer	2.64e-05	0.00054	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—pancreatic cancer	2.53e-05	0.000517	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	2.39e-05	0.000488	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARG—pancreatic cancer	2.3e-05	0.000471	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	2.1e-05	0.000429	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—pancreatic cancer	1.9e-05	0.000389	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—pancreatic cancer	1.86e-05	0.000381	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	1.83e-05	0.000374	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—pancreatic cancer	1.81e-05	0.000371	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—pancreatic cancer	1.78e-05	0.000365	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—pancreatic cancer	1.58e-05	0.000323	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—pancreatic cancer	1.52e-05	0.000311	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—pancreatic cancer	1.46e-05	0.000298	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—pancreatic cancer	1.32e-05	0.00027	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	1.11e-05	0.000228	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—pancreatic cancer	9.11e-06	0.000186	CbGpPWpGaD
